S.R.I.W.

Santero Therapeutics is focused on developing innovative antibiotics aimed at addressing the challenges posed by multi-drug-resistant pathogens. The company creates medications that employ novel mechanisms of action to effectively combat infections resistant to traditional treatments. By providing therapies that maintain prolonged efficacy, Santero aims to improve patient outcomes and offer better-tolerated options for those afflicted with difficult-to-treat infections. Through its research and development efforts, Santero Therapeutics seeks to contribute to the fight against antibiotic resistance, a growing concern in modern medicine.

Intressa Vascular focuses on developing innovative solutions for cardiovascular conditions, particularly addressing aortic dissection. The company utilizes a proprietary braiding technology platform to create multilayer stents designed for next-generation endovascular treatments. These products assist physicians in effectively managing the serious impacts of aortic dissections, ultimately aiming to enhance patient outcomes while minimizing the risk of ischemic complications. By fostering a collaborative and constructive approach, Intressa Vascular is committed to advancing patient care through high-quality medical products.

Intressa Vascular focuses on developing innovative solutions for cardiovascular conditions, particularly addressing aortic dissection. The company utilizes a proprietary braiding technology platform to create multilayer stents designed for next-generation endovascular treatments. These products assist physicians in effectively managing the serious impacts of aortic dissections, ultimately aiming to enhance patient outcomes while minimizing the risk of ischemic complications. By fostering a collaborative and constructive approach, Intressa Vascular is committed to advancing patient care through high-quality medical products.

Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.

BOTALYS is a company focused on harnessing the health benefits of medicinal plants while prioritizing environmental sustainability. By employing indoor precision farming techniques, BOTALYS cultivates potent botanicals under ultra-clean conditions, ensuring that they achieve their full health potential. The company operates one of the largest vertical farms in Europe, allowing for the optimization of growth environments that mimic natural wild conditions. BOTALYS is particularly known for developing a full-spectrum Korean red ginseng root powder, which is engineered to replicate the characteristics of a 20-year-old wild specimen. This dedication to quality and bioactivity enables BOTALYS to provide traceable and pure ingredients to emerging brands, thus advancing the understanding and application of botanical biodiversity in health products.

I-care Group is an industrial company based in Belgium, founded in 2004, that specializes in predictive and prescriptive maintenance services. The company utilizes artificial intelligence and data-driven solutions to enhance the collection and processing of industrial data, enabling clients to anticipate failures in machinery and equipment. By optimizing industrial risk management, I-care Group improves performance across business, human, and environmental dimensions. Its integrated technology expertise and asset management methods help decrease maintenance costs, increase equipment uptime, and enhance overall reliability and safety of operations. The company's focus on delivering high-quality service ensures that clients benefit from improved operational efficiency and effectiveness.

Aerospacelab SA, founded in 2017 and headquartered in Mont-Saint-Guibert, Belgium, specializes in the development and manufacture of small satellites equipped with advanced sensors. The company focuses on creating satellite imagery technology that captures high-resolution optical data, allowing for frequent data collection. In addition to satellite production, Aerospacelab develops tools that utilize artificial intelligence and machine learning to automate various tasks, facilitating processes such as surveying and monitoring. This innovative approach enables customers to efficiently analyze substantial volumes of data and optimize the extraction of valuable insights from the information gathered.

EyeD Pharma SA is a pharmaceutical company based in Liège, Belgium, specializing in the development and commercialization of innovative drug products for ophthalmology. The company focuses primarily on the treatment of glaucoma, a condition traditionally managed through daily eye drop administration. EyeD Pharma aims to enhance the quality of life for patients by creating therapies that reduce side effects associated with existing treatments. In collaboration with ophthalmologists, the company offers new treatment options and surgical products, helping to improve clinical practices and provide therapeutic assistance that is currently lacking in the market.

PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, focused on developing innovative active immunotherapies for cancer. The company specializes in a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line), which are loaded with cancer-specific antigens to stimulate a robust immune response. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, the company emerged from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. PDC*line Pharma aims to enhance cancer treatment efficacy by producing potent and scalable PDC lines that can boost antitumor responses, including the activation of neoantigens and specific cytotoxic T-cells, offering a more effective alternative to conventional vaccines.

EsoBiotec is a Belgian biotechnology company dedicated to the discovery and development of novel cancer therapies. The firm focuses on empowering the human body to combat cancer through in vivo cell engineering. By creating innovative immunotherapies, EsoBiotec aims to provide cost-effective drugs and therapeutics that enhance accessibility, ensuring that patients can receive essential cancer treatments at lower costs.

Sortlist is a company that develops an online multi-criteria searching tool designed to assist businesses in finding suitable marketing and communication agencies. By leveraging professional networks and peer-to-peer recommendations, Sortlist enables marketing managers to efficiently discover potential partners in a rapidly evolving digital landscape. The platform caters to businesses of all sizes and sectors, streamlining the process of identifying service providers that align with specific needs and criteria. This solution allows clients to focus on enhancing their communication and marketing efforts rather than spending excessive time searching for the right agency.

Vertuoza is a developer of construction software that centralizes the management of construction sites and teams, enabling professionals to focus on the core aspects of their business. The platform allows users to streamline various tasks such as editing estimates, planning work schedules, monitoring site activities, and invoicing, all accessible from a single interface. By anticipating potential issues and providing solutions, Vertuoza enhances time management and efficiency for contractors. This software not only improves operational workflows but also enhances service delivery to clients and highlights projects for architects, establishing a beneficial relationship among all parties involved. Vertuoza embodies a philosophy of being both virtuous and virtuose, signifying its commitment to excellence in construction management.

ImCyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, that specializes in developing active immunotherapies aimed at treating and preventing severe chronic autoimmune diseases linked to immune system disruptions. Founded in 2010, ImCyse utilizes a unique technology platform that focuses on the administration of Imotopes™, specifically modified peptides that generate cytolytic CD4 T-cells. These T-cells selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, targeting the underlying causes of diseases like type 1 diabetes and multiple sclerosis. ImCyse's innovative approach not only aims to provide therapeutic alternatives where none exist but also seeks to cure patients without compromising their immune defenses. The company has demonstrated proof of concept across several indications and has successfully completed its first clinical trial for type 1 diabetes, yielding promising results while developing additional Imotopes™ for various autoimmune conditions.

Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.

Syndesi Therapeutics SA is a biopharmaceutical company based in Louvain-la-Neuve, Belgium, founded in 2018. The company focuses on developing drug molecules that modulate the synaptic vesicle protein SV2A, which is crucial for synaptic transmission—the process that facilitates communication between neurons in the brain. By regulating this transmission, Syndesi aims to create effective treatments for Alzheimer’s Disease and other cognitive impairment disorders. The company holds an exclusive license to its innovative platform technology from UCB, a leader in SV2A research. Through its efforts, Syndesi Therapeutics seeks to provide healthcare providers with advanced therapeutic options for managing these challenging conditions.

Miracor Medical is a medical device company focused on developing and commercializing innovative technologies for treating severe cardiac diseases. Established in 2008 and headquartered in Awans, Belgium, the company specializes in the PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion. This system is designed to aid cardiac surgeons in treating patients who have experienced myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. The PiCSO treatment aims to enhance microvascular perfusion and improve cardiac function by increasing blood flow to damaged heart tissue, potentially reducing the risk of heart failure following acute myocardial infarction.

ExeVir Bio BV, founded in 2020 and based in Zwijnaarde, Belgium, specializes in developing single-domain antibody-based therapies aimed at combating viral infections. The company leverages a llama-derived antibody technology platform to create robust antiviral treatments that offer broad protection against coronaviruses. Notably, it is developing VHH72-FC, an antibody that targets a highly conserved region on the spikes of SARS-CoV-2, crucial for the virus's entry into human cells. ExeVir Bio's rapid response platform for antivirals allows for an agile approach to emerging health threats, enabling the swift generation of drug candidates. The therapeutics produced through this innovative technology are designed to be stable, cost-effective, and accessible on a global scale.

iTeos Therapeutics is a biopharmaceutical company dedicated to developing immuno-oncology therapies for cancer patients. Founded in 2011, the company operates from headquarters in Cambridge, Massachusetts, and Gosselies, Belgium. iTeos focuses on discovering and advancing small molecule immunomodulators that target the tumor microenvironment, aiming to enhance the body's immune response against cancer. Its pipeline includes EOS-850, a small molecule antagonist of the adenosine A2a receptor, and EOS-448, an antagonist of TIGIT, both currently in Phase 1/2a clinical trials. iTeos' approach is built on the expertise of Ludwig Cancer Research, aiming to improve clinical outcomes by restoring the immune system's ability to fight cancer.

OncoDNA, established by experts with over six decades of combined experience in medical diagnostics, specializes in precision medicine for cancer and genetic diseases. The company offers clinical guidance and real-time monitoring for late-stage cancer patients, aiding clinicians, researchers, and biopharma companies in advancing cancer and genetic disease treatments.

PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, focused on developing innovative active immunotherapies for cancer. The company specializes in a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line), which are loaded with cancer-specific antigens to stimulate a robust immune response. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, the company emerged from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. PDC*line Pharma aims to enhance cancer treatment efficacy by producing potent and scalable PDC lines that can boost antitumor responses, including the activation of neoantigens and specific cytotoxic T-cells, offering a more effective alternative to conventional vaccines.

BOTALYS is a company focused on harnessing the health benefits of medicinal plants while prioritizing environmental sustainability. By employing indoor precision farming techniques, BOTALYS cultivates potent botanicals under ultra-clean conditions, ensuring that they achieve their full health potential. The company operates one of the largest vertical farms in Europe, allowing for the optimization of growth environments that mimic natural wild conditions. BOTALYS is particularly known for developing a full-spectrum Korean red ginseng root powder, which is engineered to replicate the characteristics of a 20-year-old wild specimen. This dedication to quality and bioactivity enables BOTALYS to provide traceable and pure ingredients to emerging brands, thus advancing the understanding and application of botanical biodiversity in health products.

Odoo is an open-source platform that offers a comprehensive suite of integrated business applications aimed at managing various company operations. Its tools encompass customer relationship management (CRM), eCommerce, accounting, inventory management, point of sale, and project management, among others. These applications are designed to work cohesively, facilitating seamless workflows across different departments within a business. Odoo enables organizations to automate processes and monitor activities from any device, thus enhancing efficiency and productivity in managing their operations.

EURA NOVA, founded in 2008, in the midst of the global economic turmoil is a privately-owned company that specializes in digital transformation through AI and data. They offer data consulting, develop custom data solutions (like their Digazu platform), conduct research into emerging technologies, and prioritize a strong, collaborative company culture.

iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

ImCyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, that specializes in developing active immunotherapies aimed at treating and preventing severe chronic autoimmune diseases linked to immune system disruptions. Founded in 2010, ImCyse utilizes a unique technology platform that focuses on the administration of Imotopes™, specifically modified peptides that generate cytolytic CD4 T-cells. These T-cells selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, targeting the underlying causes of diseases like type 1 diabetes and multiple sclerosis. ImCyse's innovative approach not only aims to provide therapeutic alternatives where none exist but also seeks to cure patients without compromising their immune defenses. The company has demonstrated proof of concept across several indications and has successfully completed its first clinical trial for type 1 diabetes, yielding promising results while developing additional Imotopes™ for various autoimmune conditions.

Aerospacelab SA, founded in 2017 and headquartered in Mont-Saint-Guibert, Belgium, specializes in the development and manufacture of small satellites equipped with advanced sensors. The company focuses on creating satellite imagery technology that captures high-resolution optical data, allowing for frequent data collection. In addition to satellite production, Aerospacelab develops tools that utilize artificial intelligence and machine learning to automate various tasks, facilitating processes such as surveying and monitoring. This innovative approach enables customers to efficiently analyze substantial volumes of data and optimize the extraction of valuable insights from the information gathered.

Minoryx Therapeutics is a biotechnology company based in Mataro, Spain, founded in 2011. The company specializes in discovering and developing innovative treatments for life-threatening rare diseases, with a particular focus on pediatric neurometabolic conditions of genetic origin. Minoryx is known for its development of pharmacological chaperones, a new generation of small molecule drugs designed to restore protein functionality, thereby addressing unmet medical needs in genetic diseases that severely affect the central nervous system. Additionally, Minoryx engages in repositioning-based projects to explore alternative therapeutic options for these challenging conditions.

Walmat specializes in the distribution of building materials, catering to both retail customers and professional businesses. The company offers a wide range of products, including blocks, bricks, natural stones, metal products, and tiles, primarily for foundations and masonry work. In addition to these materials, Walmat provides associated delivery services, ensuring cost-effective solutions and timely delivery to its clients. By combining the resources of Materials Pavilion and Chantiers Beaumontois, Walmat positions itself as a reliable partner in the construction and DIY sectors.

Since 2009, VENYO has been working on a revolutionary B737NG Fixed Base Simulator (FBS) which was revealed and made its “World Premiere” at the Paris Air Show in 2013. It was the very first time that the aeronautical industry was able to view an innovative and fully functional flight simulator operated on site at Le Bourget. Being qualified as a “Game Changer” by the professional community not only confirmed but encouraged VENYO’s intention to continue to invest and move from concept to commercialization. As professionals in aviation training, we’ve understood that high-quality Fixed Base Simulators (FBS) like ours are now in demand to off-load training tasks at an unrivalled budget that would otherwise be done in an expensive Level D Full Flight Simulator (FFS). Designed from day one for the highest level of certification for a motionless training device, we are proud to provide a solution to the pilot shortage with a product allowing you to increase simulator training hours without extra costs. ‘Power-by-the-Hour’ rental model is as some may say a ‘disruptive’ approach to the market. Our flexible, monthly billing includes a minimal contractual number of hours or metered fees (if minimum is exceeded) at a predefined hourly rate. The idea is to offer a simulator at your premises which is constantly maintained to premier standards, with no hidden fees. Our goal is to offer more flexibility for the customer in terms of adjusting to the ongoing market changes in technology and training capacity. Our simulator is easy to install and to operate. It doesn’t require an empty FFS bay and a nuclear power plant nearby. Look at how one of our partners simply installed our training device in a maintenance hangar.

iTeos Therapeutics is a biopharmaceutical company dedicated to developing immuno-oncology therapies for cancer patients. Founded in 2011, the company operates from headquarters in Cambridge, Massachusetts, and Gosselies, Belgium. iTeos focuses on discovering and advancing small molecule immunomodulators that target the tumor microenvironment, aiming to enhance the body's immune response against cancer. Its pipeline includes EOS-850, a small molecule antagonist of the adenosine A2a receptor, and EOS-448, an antagonist of TIGIT, both currently in Phase 1/2a clinical trials. iTeos' approach is built on the expertise of Ludwig Cancer Research, aiming to improve clinical outcomes by restoring the immune system's ability to fight cancer.

Haulogy is a software company focused on serving distribution system operators and energy providers in the gas and electricity sectors. It develops information technology and consultancy software designed to support the energy industry. Haulogy's platform includes a range of features such as customer information systems, billing solutions, meter data management, and grid management. These tools enable distribution system operators and energy suppliers to effectively manage the entire value chain, facilitating the processing of information from individual meters to the data reflected on energy bills.

ChromaCure is engaged in the development of innovative cancer therapies, focusing on discovering first-in-class small molecule therapeutics to address unmet needs in oncology. The company is initiating a drug development program aimed at identifying new candidates that selectively and potently inhibit cancer targets. This initiative seeks to provide novel treatment options for multiple forms of cancer, either as standalone therapies or in combination with existing immunotherapy or chemotherapy approaches. Through its efforts, ChromaCure aims to enhance the therapeutic landscape for cancer patients, offering potential new solutions for various cancer types.

Epic Therapeutics is a drug discovery and development company focused on creating innovative therapeutic solutions for cancer through the field of RNA epigenetics. The company specializes in developing small molecule drugs that target RNA epigenetic mechanisms, utilizing techniques such as RNA modifications, epigenomics, and transcriptomics. This approach aims to provide life-changing therapies for cancer patients, enabling medical practitioners to offer more effective treatment options.

EcoPhos is a Belgian technology provider and leading producer of animal feed phosphates in Europe, headquartered in Louvain-La-Neuve. The company operates with a workforce of 250 employees and includes an engineering office and a demonstration unit. EcoPhos specializes in the manufacturing of inorganic feed phosphates through a process that purifies phosphoric acid and produces various phosphate salts. Its operations focus on delivering agricultural phosphate products that are free from toxic substances, thereby minimizing environmental impact. The company has two production sites with a combined capacity of 300,000 tons per annum, reinforcing its position in the market.

Invineo design and development of a "smart machine" for catering and hospitality professionals.

Air Belgium S.A., founded in 1979 and based in Mont-Saint-Guibert, Belgium, provides passenger air transportation services primarily between Brussels and Hong Kong. The airline specializes in offering quality, attractively priced intercontinental flights to selected markets in Asia. Its fleet is equipped with economy, premium, and business class seating options, catering to diverse passenger needs, including provisions for traveling with pets and children. Additionally, Air Belgium enhances the travel experience through onboard catering services, ensuring that passengers enjoy comfortable and pleasant journeys.

Tessares is a Belgian startup founded in 2015, specializing in software that enhances Internet access performance and quality. The company focuses on developing solutions based on Multipath TCP (MPTCP) technology, which allows network operators to combine multiple access technologies, effectively increasing available bandwidth and improving user experience. Tessares’ flagship offering is the Hybrid Access Solution, which creates a more efficient and faster Internet connection without the need for extensive infrastructure investments. The company was established by key developers of the MPTCP protocol and has garnered significant initial funding from Proximus and VIVES. By leveraging its technical expertise, Tessares aims to optimize the Internet experience for clients across various geographic areas.

ZenTech is a biotechnology company focused on the early detection of diseases. It specializes in developing, producing, and marketing In-Vitro Diagnostics (IVD) kits for newborn screening and pediatric use, offering non-invasive sampling methods to physicians.

Synergia Medical, established in 2013 and based in Mont-Saint-Guibert, Belgium, specializes in developing neurostimulation medical devices. The company is renowned for its innovative optoelectronic neurostimulator platform, which integrates biomaterials, optical components, biosensors, and microelectronics. Synergia's mission is to commercialize next-generation neurostimulation devices, led by a seasoned management team with extensive experience in developing implantable neurostimulators. In a short span of three years, the company achieved ISO13485 certification, created and sold an OEM external neurostimulator for a motorized amputee prosthesis arm, and developed its first version of the NAOS platform. Backed by private investors and public research grants, Synergia has grown to a team of thirteen highly skilled multidisciplinary professionals, focusing on advancing medical devices for neurostimulation using optoelectronics.

Syndesi Therapeutics SA is a biopharmaceutical company based in Louvain-la-Neuve, Belgium, founded in 2018. The company focuses on developing drug molecules that modulate the synaptic vesicle protein SV2A, which is crucial for synaptic transmission—the process that facilitates communication between neurons in the brain. By regulating this transmission, Syndesi aims to create effective treatments for Alzheimer’s Disease and other cognitive impairment disorders. The company holds an exclusive license to its innovative platform technology from UCB, a leader in SV2A research. Through its efforts, Syndesi Therapeutics seeks to provide healthcare providers with advanced therapeutic options for managing these challenging conditions.

Qualifio SA, established in 2011 and headquartered in Louvain-La-Neuve, Belgium, operates a Software as a Service (SaaS) platform that enables businesses to engage digital audiences and collect data. The platform facilitates the creation and publication of interactive campaigns, such as quizzes, polls, and contests, across various channels including websites, mobile apps, and social media. Qualifio's solution allows customers to integrate the platform with their existing CRM, DMP, or SSO systems, enabling real-time data collection and segmentation. The company's offerings also extend to increasing registrations and monetizing audiences.

Miracor Medical is a medical device company focused on developing and commercializing innovative technologies for treating severe cardiac diseases. Established in 2008 and headquartered in Awans, Belgium, the company specializes in the PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion. This system is designed to aid cardiac surgeons in treating patients who have experienced myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. The PiCSO treatment aims to enhance microvascular perfusion and improve cardiac function by increasing blood flow to damaged heart tissue, potentially reducing the risk of heart failure following acute myocardial infarction.

Ncardia is a biotechnology company focused on expediting the drug discovery and development process. The company leverages human induced pluripotent stem cell (hiPSC) technology to create predictive human cellular assay systems, which are used for safety and efficacy testing of drug candidates. Additionally, Ncardia enhances cardiovascular and neural drug screening, providing researchers and drug discovery companies with tools to better understand human disease biology. This approach aims to accelerate the overall drug discovery process, facilitating the development of safer and more effective therapeutic options.

International Drug Development Institute (IDDI) is an expert clinical trials service provider specialized in biostatistical and integrated eClinical services for pharmaceutical and biotechnology companies in several disease areas, including oncology and ophthalmology. IDDI optimizes the clinical development of drugs, biologics and devices thanks to proven statistical expertise and operational excellence.

Dim3 SA specializes in the development and marketing of clinical expert platforms and medical devices aimed at improving clinical nutrition management. The company's offerings include Scorso, an application designed for the screening and monitoring of disease-related malnutrition; Nutrow, a decision support software that optimizes clinical nutrition; and Biocorder, a mobile clinical assistant. Founded in 2013 and based in Beaufays, Belgium, Dim3 addresses the critical issue of disease-related malnutrition, which poses significant health risks and incurs substantial costs in healthcare. By providing real-time assessments of patients' nutritional status and needs through scientific algorithms, Dim3 enables healthcare professionals to make timely and effective decisions that enhance patient outcomes while reducing overall healthcare expenses.

e-peas SA is a Belgian company that specializes in designing and manufacturing electronic systems that enable energy autonomy for Internet of Things (IoT) applications. Founded in 2014 and based in Mont-Saint-Guibert, the company develops energy harvesting solutions that allow IoT devices to draw power from their environment, including sources such as solar, thermal, vibration, and radiofrequency. e-peas produces energy harvesting power management integrated circuits (PMICs) and low-power microcontrollers that enhance the performance and longevity of batteries in connected devices. By facilitating the efficient use of ambient energy, e-peas aims to reduce the need for frequent battery replacements across various sectors, including home automation, healthcare, and agriculture. The company's innovations contribute to making IoT devices smarter and more energy-efficient, ultimately striving for a future where devices can operate indefinitely without traditional power sources.

Pharmasimple SA is an online retailer specializing in medicines, cosmetics, and food supplements, operating primarily in Belgium and France. The company offers a wide range of beauty and cosmetic products, including face care, makeup, hair treatment, and body care items. Additionally, Pharmasimple provides health products such as feminine hygiene, dental hygiene, alternative medicine, hearing aids, and aromatherapy products. It also caters to men's care needs with face, body, and hair care products, as well as shaving essentials. The company's product range extends to diet and sports nutrition supplements, childcare items like nappies and baby food, and veterinary and pest control products. Founded in 2010 and based in Houdeng-Goegnies, Belgium, Pharmasimple leverages its market presence to negotiate significant discounts with partner laboratories, enabling it to offer competitive prices to customers.

Elium is a leading European knowledge-sharing solution that focuses on enhancing collaboration and knowledge management within organizations. The platform enables companies to capture, structure, and access vital information, thereby facilitating informed decision-making and fostering impactful outcomes. Elium functions as a corporate social network, allowing users to efficiently search for and share various types of information, which enhances the flow of knowledge both internally and externally. It integrates seamlessly with popular tools such as Microsoft SharePoint, Teams, G-Drive, Slack, and Workplace by Facebook, making it a versatile choice for knowledge-based organizations seeking to improve their team communications and collaboration efforts.

TConcept offers you the perfect brewing appliance, Teh®. This unique device will be launched on the market this year and will be able to provide extraordinary premium tea taste and olfactory sensation by respecting the infusion procedures. The ultimate tea experience. Fully automatic, their appliance provide to the tea an appropriate infusion vessel to enable tea leaves deliver their precious oils and ingredients. In its system, T-Concept has designed and developed a unique brewing apparatus where the internal part of the chamber (called the brewing vessel) is connected to the tea cartridge. Both are tightly sealed. The water is poured in the vessel and (being the cartridge sealed to it) gently flows into the capsule and prevent a thermal shock to raw material. Their brewing appliance has many capacities, including a recognition system by colors which allows him to select the appropriate temperature for each type of tea (each one of them possess her own color). It's also capable of performing an automatic rinsing and a capsule ejection, can display the brewing time, the temperature and the progress percentage for each brewing. And he can do it all with a contemporary design, giving you the feeling of meeting a real tea expert. Their capsules, with their special and transparent packaging, allow you too see the tea, his color and his ingredients and even smell all of his aromas and to make the perfect choice.

Performance for Assets SA is a Belgium-based company that specializes in developing software for machinery and operations management. The firm offers a data mining and analysis tool designed to assist companies in operations and maintenance by detecting warnings, identifying root causes of machinery failures, and analyzing machine behavior. Its solutions are tailored for industrial manufacturers and wind energy companies, providing a unique approach to optimize and manage process data related to rotating machines. By leveraging a collaborative analytical platform, Performance for Assets converts large data sets into actionable intelligence, enabling clients to effectively manage and enhance critical assets and production processes.

IONICS is a manufacturer and supplier focused on developing specialized surface treatment products for metal, glass, and various other substrates. The company offers a range of innovative and functionalized surface treatments, including plasma sputtering, ion implantation, and electroplating. These technologies are designed to provide optimized and sustainable solutions for surface coating applications. By catering to the needs of demanding clients, IONICS emphasizes responsiveness and innovation in its service offerings.

Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):

Bodair SA specializes in the design, development, and production of carbon fiber rods, primarily serving the aerospace industry. Established in 2009 and headquartered in Oupeye, Belgium, the company utilizes pre-impregnated carbon fiber filament winding technology to create a range of rods, including those with adjustable ends, fixed ends, fork-type ends, and models equipped with a measurement of effort system. Bodair's advanced designs deliver significant weight savings compared to traditional stainless steel or aluminum rods, providing clients with durable solutions that enhance performance and efficiency.

Quality Partner, established in 2000 as a spin-off from the University of Liège, specializes in food quality control measures, providing a range of services such as research, analyses, appraisals, audits, inspections, and certifications for food safety. With a team of over 75 professionals, the company conducts approximately 250,000 analyses and 15,000 audits annually across various sectors including agri-food, health, and the environment. Quality Partner is committed to delivering personalized, efficient, and cost-effective solutions that meet the highest industry standards. By integrating multidisciplinary expertise and focusing on client needs, the company aims to enhance quality systems and provide clear, actionable results that add value to its customers.

Françoise's Tartes makes simple, honest, homemade cakes and tarts.

Mydibel is a producer based in Mouscron, Belgium, specializing in a diverse array of potato products. The company offers both deep-frozen and dried options, including classic items like French fries and mashed potatoes, as well as various specialty products that cater to different tastes and preferences. Mydibel's portfolio encompasses fresh, frozen, and dehydrated potato products, ensuring a wide selection for consumers and foodservice businesses alike.

Opinum, headquartered in Braine l'Alleud, Belgium, specializes in developing digital web-based software that focuses on energy and environmental data management. The company's flagship product, the Opinum Data Hub, supports energy and environmental stakeholders in their digital transformation by facilitating all stages of the data management value chain. This platform allows users, primarily large private and public service companies, energy suppliers, and energy management experts, to analyze and visualize data related to asset consumption, including gas, water, and electricity. By enabling businesses to track and regulate their energy usage, Opinum empowers them to focus on their core competencies while effectively managing their energy consumption.

Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Its primary product, the Genio system, is a user-centered, bilateral neurostimulation therapy that has received CE-Mark validation. OSA is a prevalent condition linked to significant health risks, including increased mortality and various comorbidities such as cardiovascular diseases, depression, and stroke. Nyxoah aims to address these critical health challenges through its advanced therapeutic offerings.

ISSOL is a manufacturer and developer specializing in active materials and glazing within the construction and glass industries. The company is committed to creating solutions that evoke emotion while aligning with the sustainable image requirements of its clients. By focusing on the green energy architectural sector, ISSOL develops positive energy applications that enable buildings to generate their own electricity from solar energy. This innovation supports architects globally in realizing iconic and environmentally friendly projects, contributing to a more sustainable future.

Scidus is a producer of lumber focused on providing sustainable alternatives to exotic wood. The company specializes in a variety of hardwoods, including beech, oak, ash, and poplar, which are processed at its sawmill equipped with advanced thermal treatment technology. This technique enhances the durability and reliability of the wood products. Scidus offers an array of products, such as Torréfié® wood, Cloisobois®, machined logs, double curvature hulls, and beech boards, which are suitable for applications like cladding, terraces, and parquet floors. By prioritizing both quality and sustainability, Scidus aims to meet the growing demand for eco-friendly building materials.

Diagenode is an international life sciences company established in 2003 in Liège, Belgium, with a presence in Sparta, New Jersey, and a sales office in the United Kingdom. The company specializes in developing and commercializing advanced instruments and reagent systems for life science research and molecular diagnostics. Diagenode offers a technology platform that includes Bioruptor shearing and IP-Star automation instruments, along with reagent kits and quality antibodies. These products are designed to enhance workflows in epigenetics research, biological sample preparation, and diagnostic assays, serving a diverse clientele that includes prominent epigenetics researchers, academic institutions, genome centers, core laboratories, and pharmaceutical and biotechnology companies.

Keybate is a technology company that specializes in enhancing conference attendee engagement. Its flagship product is a mobile application that transforms attendees' smartphones into high-quality wireless microphones, enabling real-time Q&A and interaction with speakers. The app also offers features such as event guides, speaker information, agenda management, document sharing, networking tools, private messaging, live polls, and an audience response system. By integrating these functionalities, Keybate aims to streamline and improve the conference experience for both attendees and organizers.

iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Opinum, headquartered in Braine l'Alleud, Belgium, specializes in developing digital web-based software that focuses on energy and environmental data management. The company's flagship product, the Opinum Data Hub, supports energy and environmental stakeholders in their digital transformation by facilitating all stages of the data management value chain. This platform allows users, primarily large private and public service companies, energy suppliers, and energy management experts, to analyze and visualize data related to asset consumption, including gas, water, and electricity. By enabling businesses to track and regulate their energy usage, Opinum empowers them to focus on their core competencies while effectively managing their energy consumption.

TSF.be S.A. specializes in the sales, leasing, and rental of equipment for the entertainment industry, focusing on film and television production. The company offers a wide range of products including drones, cameras, tripods, audio and lighting equipment, video mixers, and more. In addition to equipment rental and sales, TSF.be provides various services such as camera testing, project management, maintenance, and after-sales support. The company also conducts training and workshops, as well as consulting services related to audiovisual equipment. Incorporated in 2009, TSF.be is headquartered in Liège, Belgium.

Paprika is a privately held company that operates a chain of fashion stores focused on the plus-size and transitional-size womenswear market. The company offers a youthful and dynamic collection of apparel specifically designed for fashion-minded larger-sized women. Through its retail outlets and online store, Paprika aims to provide trendy clothing options that empower women with fuller figures to express their personal style without facing discrimination based on size.

Any-Shape S.A., founded in 2015 and located in Flémalle, Belgium, specializes in 3D printing and additive manufacturing services tailored for industrial manufacturers. The company serves various sectors, including aerospace, defense, energy, medical, rail, and automotive industries. Any-Shape offers a comprehensive range of services that encompass design optimization, engineering, and both metal and plastic additive manufacturing. Additionally, the company provides rapid prototyping and laboratory testing services, effectively delivering a complete value chain in additive manufacturing from initial design to production and post-treatment.

Decube Group is a company based in Strépy-Bracquegnies, Belgium, specializing in technical and industrial services, including engineering, assembly, and industrial painting. The company focuses on providing solutions that help clients prevent corrosion and modify the surface of manufactured parts to achieve specific aesthetic and functional requirements. By offering a range of services under one roof, Decube enables its clients to streamline their operations and maintain the quality and appearance of their products.

Opinum, headquartered in Braine l'Alleud, Belgium, specializes in developing digital web-based software that focuses on energy and environmental data management. The company's flagship product, the Opinum Data Hub, supports energy and environmental stakeholders in their digital transformation by facilitating all stages of the data management value chain. This platform allows users, primarily large private and public service companies, energy suppliers, and energy management experts, to analyze and visualize data related to asset consumption, including gas, water, and electricity. By enabling businesses to track and regulate their energy usage, Opinum empowers them to focus on their core competencies while effectively managing their energy consumption.

Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.

CluePoints Inc. is a company that specializes in developing cloud-based software for risk-based quality management and monitoring, primarily serving pharmaceutical companies and contract research organizations (CROs). Founded in 2012 and headquartered in King of Prussia, Pennsylvania, with an additional office in Louvain-la-Neuve, Belgium, CluePoints offers solutions designed to identify, visualize, manage, and document risks associated with clinical trials. Its flagship product utilizes advanced statistical algorithms to assess the quality, accuracy, and integrity of clinical trial data both during and after studies. By adhering to guidelines from regulatory bodies such as the ICH, FDA, and EMA, CluePoints supports traditional on-site monitoring and medical reviews while driving effective risk-based monitoring strategies. The software is notable for its ability to detect anomalous data and site errors, ultimately enhancing clinical data quality, optimizing on-site monitoring efforts, and reducing the risks associated with regulatory submissions.

Mithra Pharmaceuticals SA develops, manufactures, and markets innovative therapeutics focused on women's health, particularly in the areas of contraception, menopause, and hormone-dependent cancers. The company's key development candidates include Estelle, a fifth-generation oral contraceptive that has completed phase III clinical trials, and Donesta, a next-generation hormone therapy for menopausal symptoms currently in phase III trials. Additionally, Mithra is advancing several other products, such as Myring, a contraceptive vaginal ring, and Zoreline, a biodegradable implant for treating prostate and breast cancers. Established in 1999 and headquartered in Liège, Belgium, Mithra Pharmaceuticals operates in multiple regions, including Belgium, Europe, and beyond, and offers a comprehensive spectrum of services through its CDMO, catering to research, development, and specialist manufacturing needs.

ChanvrEco S.A., founded in 2007 and based in Tinlot, Belgium, specializes in the manufacture of standard granulate derived from hemp straw, primarily for use in thermal and acoustic insulation. The company's flagship product, Prohemp, is an aggregate made from hemp that is specifically designed for building insulation applications. ChanvrEco serves the construction industry, contributing to sustainable building practices through its eco-friendly materials.

Advanced Mechanical and Optical Systems S.A., established in 1983 and based in Liege, Belgium, specializes in the manufacture and development of high-precision optomechanical equipment tailored for the fields of astronomy and space research. The company provides a range of products, including telescopes, components, and instrumentation for major observatories, as well as mirrors, mounts, and frameworks designed for satellites and space shuttles. Additionally, AMOS develops terrestrial satellite test equipment that simulates space conditions to validate satellites or payloads prior to launch, utilizing technologies such as vacuum chambers, thermal panels, and artificial stars for testing. The company operates in three primary sectors: professional astronomy systems, space systems, and satellite testing equipment.

Ncardia is a biotechnology company focused on expediting the drug discovery and development process. The company leverages human induced pluripotent stem cell (hiPSC) technology to create predictive human cellular assay systems, which are used for safety and efficacy testing of drug candidates. Additionally, Ncardia enhances cardiovascular and neural drug screening, providing researchers and drug discovery companies with tools to better understand human disease biology. This approach aims to accelerate the overall drug discovery process, facilitating the development of safer and more effective therapeutic options.

Proxistore is a developer of a local online advertising platform designed for both large retail chains and small businesses. The company utilizes its patented geolocation search engine to deliver localized advertising across various devices, including mobiles, tablets, and computers, as well as in diverse environments such as websites and applications. This innovative approach enables merchants and store chains to enhance customer traffic and attract new clientele directly at their points of sale. By focusing on localized advertising, Proxistore aims to improve the visibility and reach of its clients within their respective markets.

IBA engages in the distribution of crop protection and cattle feed products.

Lasea designs and manufactures industrial laser machines tailored for applications in various sectors, including medical, luxury, pharmaceutical, electronics, and automotive industries. The company specializes in femtosecond laser micromachining, providing services such as welding, marking, engraving, cutting, drilling, texturing, and thin film removal. By focusing on these advanced laser technologies, Lasea enables clients to utilize efficient and reliable solutions for their specific manufacturing needs.

Odoo is an open-source platform that offers a comprehensive suite of integrated business applications aimed at managing various company operations. Its tools encompass customer relationship management (CRM), eCommerce, accounting, inventory management, point of sale, and project management, among others. These applications are designed to work cohesively, facilitating seamless workflows across different departments within a business. Odoo enables organizations to automate processes and monitor activities from any device, thus enhancing efficiency and productivity in managing their operations.

Pierret is a manufacturer specializing in exterior joinery, producing doors and windows made from PVC, aluminum, wood, and wood-aluminum. The company emphasizes quality and innovation, ensuring that its products meet the highest industry standards through rigorous research and development efforts. Pierret's doors and windows are fully customizable, offering features such as sound insulation and resistance to burglary, making them suitable for various customer needs. Additionally, the performance of these products, including their resistance to air, water, and wind, as well as their acoustic properties, is validated through testing in certified and independent laboratories.

Fruytier Group is a prominent player in the European softwood processing industry, involved in every stage of the timber supply chain, from sourcing round wood to delivering finished products. The company specializes in providing sawn wood for various applications, including structures, packaging, siding, and outdoor decking, primarily using Spruce and Douglas Fir sourced from local, sustainable timber resources. In addition to sawn wood, Fruytier Group supplies sawmill by-products such as pellets, sawdust, chips, and bark. Its services encompass sawing and grading, high-precision re-cutting, drying, planing, moulding, and treatment processes like dipping and high-pressure impregnation. Positioned in the heart of Europe, Fruytier Group efficiently processes over 1 million cubic meters of timber annually across its facilities in Belgium, Germany, and France, ensuring high-quality products with quick turnaround times for its partners in sectors such as prefabricated housing and retail.

Trendy Foods Belgium is a distributor of a diverse range of food products, primarily focusing on confectionery items. The company serves Belgium and other European markets, providing an extensive selection that includes beverages, frozen foods, soft drinks, alcoholic beverages, flowers, plants, seasonal items, and fruits. This broad assortment enables customers to select from a variety of desired products, catering to different tastes and preferences.

iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Allmat is a leading group in Wallonia specializing in building materials, wood, and professional tools. The company operates 13 retail locations under the Allmat brand across various towns, including Andenne, Ciney, Beauraing, and Seraing, as well as a wood specialist store known as SA BOISMAT. Allmat offers a wide range of products such as ceramic tiles, wood, and tools, which are accessible to both professional and private customers. Customers can purchase items directly from the stores or utilize personalized delivery options, ensuring convenient access to essential construction materials.

Lampiris N.V., founded in 2003 and based in Liège, Belgium, is an independent supplier of electricity and gas, serving both private individuals and businesses. The company has been active in the Belgian energy market since 2005 and has established itself as the third-largest supplier in the residential sector, with over a million accounts. In addition to energy supply, Lampiris offers various energy services, including insulation, furnace maintenance, and heating solutions using wood and pellets, as well as smart thermostats. As of September 2016, Lampiris operates as a subsidiary of Elf Aquitaine S.A.

Icarus Group S.A., headquartered in Herstal, Belgium, is a holding company that specializes in the manufacturing of valves, flanges, and piping products for the oil and gas industry. The company serves as a single-source supplier, providing complete piping packages and bespoke products designed for onshore, offshore, and subsea applications. Icarus manufactures a variety of items, including seamless and welded pipes, tubes, forged fittings, and flanges, utilizing materials such as alloy and stainless steels, nickel alloys, and titanium. Through its subsidiaries, Icarus aims to meet diverse client requirements in the energy sector, ensuring comprehensive solutions for all piping needs.

KitoZyme S.A. is a biotechnology company based in Herstal, Belgium, specializing in the development and production of biopolymers derived from non-animal sources, particularly chitosan and chitin-glucan. The company serves various markets, including nutraceuticals, cosmetics, beverages, and pharmaceuticals. In the nutraceutical sector, KitoZyme offers products such as KiOnutrime-Cs for weight management and KiOnutrime-CG for oxidative stress management. Its cosmetic line features KiOsmetine-CG, a multifunctional ingredient for skin care, and KiOsmetine-S, a plant-based alternative to silicone. For the beverage industry, KitoZyme provides KiOfine-CG, a fining agent for wines, and KiOfine-B, a processing aid for contaminant removal. In pharmaceuticals, it develops KiOmedine for applications in wound management and drug delivery systems. KitoZyme's commitment to innovation is supported by scientifically proven technologies, and it distributes its products through partners across multiple countries, including the United States and various European nations.

Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.

EURODV specializes in the design, manufacture, and installation of doors and partitions, including plain, glass, and high-performance metal options. The company focuses on providing door security technology tailored for the building and construction market. Its product offerings include steel doors, frames, and advanced options such as fireproof, anti-burglary, and bulletproof doors. By supplying these high-quality and innovative solutions, EURODV supports infrastructure companies in delivering superior products to their customers.

Spacebel is a company specializing in space systems and software engineering, focusing on applications in the space sector and earth observation. It serves a diverse clientele that includes space agencies, prime contractors, European institutions, and the commercial sector. The company develops a platform that facilitates mission definition, analysis, and the study of complete minisatellite systems. Its offerings encompass both onboard and ground segment products tailored for space observation and telecommunication applications. This enables clients to effectively monitor environmental conditions both on Earth and in space.

iTeos Therapeutics is a biopharmaceutical company dedicated to developing immuno-oncology therapies for cancer patients. Founded in 2011, the company operates from headquarters in Cambridge, Massachusetts, and Gosselies, Belgium. iTeos focuses on discovering and advancing small molecule immunomodulators that target the tumor microenvironment, aiming to enhance the body's immune response against cancer. Its pipeline includes EOS-850, a small molecule antagonist of the adenosine A2a receptor, and EOS-448, an antagonist of TIGIT, both currently in Phase 1/2a clinical trials. iTeos' approach is built on the expertise of Ludwig Cancer Research, aiming to improve clinical outcomes by restoring the immune system's ability to fight cancer.

Dragone is a creative company based in La Louviere, Belgium, specializing in the production of theatrical performances. The company operates customized theaters designed to enhance the audience's experience and hosts a variety of artistic events, including ballet and opera. In addition to organizing these entertainment shows, Dragone is involved in the design of costumes and the writing of stories, effectively merging human talent, artistic disciplines, and technical innovations to bring captivating narratives to life. Through its diverse offerings, Dragone aims to create memorable experiences for audiences.

GreenWatt is a CleanTech company specializing in the development of anaerobic digestor plants that convert organic waste into renewable energy. The company provides comprehensive engineering services, including feasibility studies, construction, and the startup of turn-key small-scale biogas plants. Utilizing innovative and patented technologies, GreenWatt addresses key challenges associated with anaerobic digestion. Its installations are designed to integrate locally within the agro-food and beverage industries, offering a cost-effective and efficient solution for waste management and energy production.

Rentel, a Belgian company, specializes in offshore wind energy. It develops, finances, constructs, and operates offshore wind parks in the Belgian North Sea, with potential expansion abroad.

Alysse Food S.A. is a bakery company based in Seneffe, Belgium, specializing in the production of American-style baked goods, including bagels, muffins, brownies, and cupcakes. Established in 1995, Alysse Food operates in Brussels and functions as a subsidiary of Patisseries Gourmandes SA. The company is focused on delivering high-quality bakery products to meet consumer demands in the market.

Eurogare sa is a design office that focuses on providing construction design and consulting services primarily for the railway and infrastructural sectors. The company specializes in the technical study, monitoring, and implementation of various projects, including railway terminals, signal booths, infrastructure logistics centers, workshops, car parks, and office buildings. Eurogare aims to support the development and maintenance of essential infrastructure, ensuring that projects are executed efficiently and effectively.

Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):

Xylowatt S.A. is a Belgian company based in Louvain-La-Neuve that focuses on developing gasification reactors to convert biomass and waste products into renewable energy. Founded in 2001, the company specializes in its NOTAR technology, which allows for energy production from a variety of contaminated residues, including different types of wood waste and sewage sludge. Xylowatt also offers oxy-gasification solutions and expert services, catering to engineering, procurement, and construction (EPC) contractors, industrial customers, and research and development departments. The company's industrial gasifiers are designed to produce clean syngas without tar residues, integrating cogeneration engines to convert wood chips into valuable energy, thereby enabling clients to benefit from locally sourced green energy. Xylowatt operates as a subsidiary of Icafin SA/NV.

Carmeuse is a global manufacturer specializing in lime, high-calcium limestone, and dolomitic stone, offering a diverse range of mineral-based products. The company serves various sectors, including chemical, agricultural, engineering, environmental, steel, glass, and ceramics industries. Carmeuse extracts and processes high-calcium limestone and dolomite into lime and lime-related products tailored to meet the specific needs of industrial and commercial customers. In addition to its production capabilities, Carmeuse provides customized equipment and engineering solutions for plant operations, storage, and product transfer, thereby helping clients optimize their processes, enhance safety, and reduce their carbon footprint.